查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404699

犬疫苗市場規模、佔有率、趨勢分析報告：依疫苗類型、疾病類型、給藥途徑、免疫期、成分、地區、細分市場預測，2023-2030年

Dog Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type, By Disease Type, By Route Of Administration, By Duration Of Immunity, By Component, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 115 Pages | 商品交期: 2-10個工作天內

價格

犬疫苗市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球狗疫苗市場規模預計將達到26億美元，預測期內複合年成長率為6.0%。

這種成長是由寵物人性化、千禧世代養寵物以及預防性醫療保健意識增強等趨勢所推動的。根據勃林格殷格翰國際有限公司的數據，35% 的千禧世代和 32% 的嬰兒潮世代擁有寵物。此外，寵物支出和保險的增加預計也將推動該市場的成長。根據 WorldAnimalFoundation.org 2023 年 2 月發表的報導，狗飼主比貓飼主多花費約 570 美元。

此外，寵物數量的增加、中國和印度等亞太新興市場收入水準的提高以及隨之而來的人們生活方式的變化預計將對狗疫苗行業的成長產生重大影響。例如，根據《經濟時報》2023年7月發表的報導，印度人均收入預計將成長1.6倍，到2030年達到4,000美元。

犬疫苗市場報告亮點

  • 按疫苗類型分類，改良/減毒活病毒疫苗領域在 2022 年佔據最大銷售佔有率，為 52.4%，因為它有助於預防疾病並提供長期免疫力。
  • 按疾病類型分類，由於犬狂犬病的高盛行率和通用感染疾病，預計在預測期內，犬狂犬病將以 6.9% 的最快複合年成長率成長。
  • 從給藥途徑來看，注射劑佔銷售額的最大佔有率，到2022年將達到76.1%，因為注射劑非常方便且給藥準確。
  • 依免疫期限分類，一年期給藥型由於便利性高，2022年佔51.2%的佔有率。
  • 以成分來看，組合疫苗佔比最大，為 65.5%。由於其能夠預防多種疾病，預計在預測期內將以 6.2% 的複合年成長率成長最快。
  • 由於大公司的存在以及對寵物預防性保健意識的提高，北美在 2022 年佔據主導地位，佔 38.8% 的佔有率。同時，由於中國和印度等新興經濟體開拓的商機，預計亞太地區在預測期內將以 7.0% 的複合年成長率成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章犬疫苗市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 狗狗疫苗市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 犬用疫苗：疫苗種類估算及趨勢分析

  • 狗狗疫苗市場：重點
  • 狗疫苗市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 改良/減毒活病毒疫苗
    • 2018-2030 年變性/減毒活病毒疫苗市場估計與預測
  • 惰性（失活）
    • 惰性
  • 其他
    • 2018-2030 年其他市場估計與預測

第5章犬疫苗：疾病類型估計與趨勢分析

  • 狗狗疫苗市場：重點
  • 狗疫苗市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 犬瘟熱
    • 2018-2030 年犬瘟熱市場估計與預測
  • 犬傳染性呼吸道疾病綜合體 (CIRDC)
    • 犬傳染性呼吸道疾病複合體
  • 犬小病毒病/小病毒病
    • 2018-2030 年犬細小病毒病/細小病毒病市場估計與預測
  • 犬鉤端螺旋體病
    • 2018-2030 年犬鉤端螺旋體病市場估計與預測
  • 犬萊姆病
    • 2018-2030 年犬萊姆病市場估計與預測
  • 犬傳染性肝炎
    • 2018-2030年犬傳染性肝炎市場估計與預測
  • 狗狂犬病
    • 2018-2030 年犬狂犬病市場估計與預測
  • 其他疾病
    • 2018-2030 年其他疾病市場估計與預測

第6章 犬疫苗：給藥途徑的估算與趨勢分析

  • 狗狗疫苗市場：重點
  • 狗疫苗市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 可注射的
    • 2018-2030 年注射劑市場估計與預測
  • 鼻內
    • 2018-2030年鼻內市場估計與預測
  • 口服
    • 2018-2030 年口腔市場估計與預測

第7章 犬用疫苗：免疫估計與趨勢分析

  • 狗狗疫苗市場：重點
  • 狗疫苗市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 1年
    • 2018-2030 年 1 年市場估計與預測
  • 3年
    • 2018-2030 年 3 年市場估計與預測
  • 其他
    • 2018-2030 年其他市場估計與預測

第 8 章 犬疫苗：成分估算與趨勢分析

  • 狗狗疫苗市場：重點
  • 狗疫苗市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 聯合疫苗
    • 2018-2030 年聯合疫苗市場估計與預測
  • 單一疫苗
    • 2018-2030 年單一疫苗市場估計與預測

第9章狗疫苗市場：區域估計和趨勢分析

  • 區域展望
  • 按地區分類的狗疫苗市場：要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030 年市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Bioveta, as
    • HESTER BIOSCIENCES LIMITED
    • Boehringer Ingelheim International GmbH
    • Brilliant Bio Pharma
    • Heska Corporation
    • Merck & Co., Inc.
    • Virbac
    • Zendal group
    • Elanco
    • Zoetis Services LLC
Product Code: GVR-4-68040-156-3

Dog Vaccine Market Growth & Trends:

The global dog vaccine market size is anticipated to reach USD 2.6 billion by 2030 and display a CAGR of 6.0% during the forecast period, according to a new report by Grand View Research, Inc. The growth can be attributed to the increasing trend of pet humanization, pet ownership among millennials, and rising consciousness regarding preventive healthcare. According to Boehringer Ingelheim International GmbH, 35% of millennials and 32% of baby boomers own a pet. In addition, the rise in pet spending and insurance is also expected to add to the growth of this market. According to an article published by WorldAnimalFoundation.org in February 2023, dog owners spent approximately USD 570 more than cat owners.

Moreover, the increasing pet population, rising income levels in emerging markets of Asia-Pacific, such as China and India, and consequent changes in the lifestyle of people are expected to impact the growth of the dog vaccine industry significantly. For instance, according to an article published by the Economic Times in July 2023, the per capita income in India is expected to increase by 1.6 times to reach USD 4000 by 2030.

Dog Vaccine Market Report Highlights:

  • Based on vaccine type, the modified/attenuated live vaccine segment accounted for the largest revenue share of 52.4% in 2022, as they help prevent disease and provide long-term immunity
  • Based on disease type, the canine rabies segment is expected to grow at the fastest CAGR of 6.9% over the forecast period due to the high prevalence of this disease and its zoonotic potential
  • Based on route of administration, the injectable segment accounted for the largest revenue share of 76.1% in 2022, owing to their convenience and ability to administer accurate dosage amounts
  • Based on duration of immunity, the 1-year segment dominated the market with a share of 51.2% in 2022 owing to their convenience
  • Based on component, the combined vaccines segment accounted for the largest market share of 65.5%. It is expected to grow at the fastest CAGR of 6.2% over the forecast period due to its ability to protect against more than one disease
  • North America dominated with a share of 38.8% in 2022, owing to the presence of major players and increasing awareness regarding preventive healthcare for pets. On the other hand, Asia Pacific is anticipated to grow at the fastest CAGR of 7.0% over the forecast period due to untapped opportunities in the emerging economies of China and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Vaccine type
    • 1.1.2. Disease type
    • 1.1.3. Route of administration
    • 1.1.4. Duration of immunity
    • 1.1.5. Component
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Vaccine type outlook
    • 2.2.2. Disease type outlook
    • 2.2.3. Route of administration outlook
    • 2.2.4. Duration of immunity outlook
    • 2.2.5. Component outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Dog Vaccine Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Dog Vaccine Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Dog Vaccine: Vaccine Type Estimates & Trend Analysis

  • 4.1. Dog Vaccine Market: Key Takeaways
  • 4.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Modified/Attenuated Live
    • 4.3.1. Modified/ attenuated live market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Inactivated (Killed)
    • 4.4.1. Inactivated (Killed) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Dog Vaccine: Disease Type Estimates & Trend Analysis

  • 5.1. Dog Vaccine Market: Key Takeaways
  • 5.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Canine Distemper
    • 5.3.1. Canine distemper market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Canine Infectious Respiratory Disease Complex (CIRDC)
    • 5.4.1. Canine infectious respiratory disease complex (CIRDC) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Canine Parvovirosis/ Parvovirus Disease
    • 5.5.1. Canine parvovirosis/ parvovirus disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Canine Leptospirosis
    • 5.6.1. Canine leptospirosis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Canine Lyme Disease
    • 5.7.1. Canine lyme disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Infectious Canine Hepatitis
    • 5.8.1. Infectious canine hepatitis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Canine Rabies
    • 5.9.1. Canine distemper market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.10. Other Diseases
    • 5.10.1. Other diseases market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Dog Vaccine: Route of Administration Estimates & Trend Analysis

  • 6.1. Dog Vaccine Market: Key Takeaways
  • 6.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Injectable
    • 6.3.1. Injectable market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Intranasal
    • 6.4.1. Intranasal market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Oral
    • 6.5.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Dog Vaccine: Duration of Immunity Estimates & Trend Analysis

  • 7.1. Dog Vaccine Market: Key Takeaways
  • 7.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. 1 Year
    • 7.3.1. 1-year market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. 3 Year
    • 7.4.1. 3-year market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Dog Vaccine: Component Estimates & Trend Analysis

  • 8.1. Dog Vaccine Market: Key Takeaways
  • 8.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
  • 8.3. Combined Vaccines
    • 8.3.1. Combined vaccines market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4. Mono Vaccines
    • 8.4.1. Mono vaccines market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Dog Vaccine Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Outlook
  • 9.2. Dog Vaccine Market by Region: Key Takeaways
  • 9.3. North America
    • 9.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework/reimbursement structure
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework/reimbursement structure
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.4. Europe
    • 9.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework/reimbursement structure
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework/reimbursement structure
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework/reimbursement structure
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework/reimbursement structure
      • 9.4.5.3. Competitive scenario
      • 9.4.5.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework/reimbursement structure
      • 9.4.6.3. Competitive scenario
      • 9.4.6.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework/reimbursement structure
      • 9.4.7.3. Competitive scenario
      • 9.4.7.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Regulatory framework/reimbursement structure
      • 9.4.8.3. Competitive scenario
      • 9.4.8.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key country dynamics
      • 9.4.9.2. Regulatory framework/reimbursement structure
      • 9.4.9.3. Competitive scenario
      • 9.4.9.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.2. China
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.3. India
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.4. Australia
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework/reimbursement structure
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.5. Thailand
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework/reimbursement structure
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.6. South Korea
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework/reimbursement structure
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.6.2. Mexico
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/reimbursement structure
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Market Participant Categorization
    • 10.2.1. Bioveta, a.s.
      • 10.2.1.1. Company overview
      • 10.2.1.2. Financial performance
      • 10.2.1.3. Product benchmarking
      • 10.2.1.4. Strategic initiatives
    • 10.2.2. HESTER BIOSCIENCES LIMITED
      • 10.2.2.1. Company overview
      • 10.2.2.2. Financial performance
      • 10.2.2.3. Product benchmarking
      • 10.2.2.4. Strategic initiatives
    • 10.2.3. Boehringer Ingelheim International GmbH
      • 10.2.3.1. Company overview
      • 10.2.3.2. Financial performance
      • 10.2.3.3. Product benchmarking
      • 10.2.3.4. Strategic initiatives
    • 10.2.4. Brilliant Bio Pharma
      • 10.2.4.1. Company overview
      • 10.2.4.2. Financial performance
      • 10.2.4.3. Product benchmarking
      • 10.2.4.4. Strategic initiatives
    • 10.2.5. Heska Corporation
      • 10.2.5.1. Company overview
      • 10.2.5.2. Financial performance
      • 10.2.5.3. Product benchmarking
      • 10.2.5.4. Strategic initiatives
    • 10.2.6. Merck & Co., Inc.
      • 10.2.6.1. Company overview
      • 10.2.6.2. Financial performance
      • 10.2.6.3. Product benchmarking
      • 10.2.6.4. Strategic initiatives
    • 10.2.7. Virbac
      • 10.2.7.1. Company overview
      • 10.2.7.2. Financial performance
      • 10.2.7.3. Product benchmarking
      • 10.2.7.4. Strategic initiatives
    • 10.2.8. Zendal group
      • 10.2.8.1. Company overview
      • 10.2.8.2. Financial performance
      • 10.2.8.3. Product benchmarking
      • 10.2.8.4. Strategic initiatives
    • 10.2.9. Elanco
      • 10.2.9.1. Company overview
      • 10.2.9.2. Financial performance
      • 10.2.9.3. Product benchmarking
      • 10.2.9.4. Strategic initiatives
    • 10.2.10. Zoetis Services LLC
      • 10.2.10.1. Company overview
      • 10.2.10.2. Financial performance
      • 10.2.10.3. Product benchmarking
      • 10.2.10.4. Strategic initiatives

List of Tables

  • 1. List of abbreviations
  • 2. North America dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 3. North America dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 4. North America dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 5. North America dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 6. North America dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 7. North America dog vaccine market, by region, 2018 - 2030 (USD Million)
  • 8. U.S. dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 9. U.S. dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 10. U.S. dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 11. U.S. dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 12. U.S. dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 13. Canada dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 14. Canada dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 15. Canada dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 16. Canada dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 17. Canada dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 18. Europe dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 19. Europe dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 20. Europe dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 21. Europe dog vaccine market, by duration of immunity type, 2018 - 2030 (USD Million)
  • 22. Europe dog vaccine market, by component type, 2018 - 2030 (USD Million)
  • 23. Europe dog vaccine market, by region, 2018 - 2030 (USD Million)
  • 24. UK dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 25. UK dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 26. UK dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 27. UK dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 28. UK dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 29. Germany dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 30. Germany dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 31. Germany dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 32. Germany dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 33. Germany Dog Vaccine market, by component, 2018 - 2030 (USD Million)
  • 34. France dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 35. France dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 36. France dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 37. France dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 38. Italy dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 39. Italy dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 40. Italy dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 41. Italy dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 42. Italy dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 43. Spain dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 44. Spain dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 45. Spain dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 46. Spain dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 47. Spain dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 48. Sweden dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 49. Sweden dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 50. Sweden dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 51. Sweden dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 52. Sweden dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 53. Norway dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 54. Norway dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 55. Norway dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 56. Norway pain dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 57. Norway dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 58. Denmark dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 59. Denmark dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 60. Denmark dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 61. Denmark dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 62. Denmark dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 63. Asia-Pacific dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 64. Asia-Pacific dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 65. Asia-Pacific dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 66. Asia-Pacific dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 67. Asia-Pacific dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 68. Asia pacific dog vaccine market, by region, 2018 - 2030 (USD Million)
  • 69. Japan dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 70. Japan dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 71. Japan dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 72. Japan dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 73. Japan dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 74. China dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 75. China dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 76. China dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 77. China dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 78. China dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 79. India dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 80. India dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 81. India dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 82. India dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 83. India dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 84. Australia dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 85. Australia dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 86. Australia dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 87. Australia dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 88. Australia dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 89. Thailand dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 90. Thailand dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 91. Thailand dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 92. Thailand dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 93. Thailand dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 94. South Korea dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 95. South Korea dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 96. South Korea dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 97. South Korea dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 98. South Korea dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 99. Latin America dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 100. Latin America dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 101. Latin America dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 102. Latin America dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 103. Latin America dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 104. Latin America Dog Vaccine market, by region, 2018 - 2030 (USD Million)
  • 105. Brazil dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 106. Brazil dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 107. Brazil dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 108. Brazil dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 109. Brazil dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 110. Mexico dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 111. Mexico dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 112. Mexico dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 113. Mexico dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 114. Mexico dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 115. Argentina dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 116. Argentina dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 117. Argentina dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 118. Argentina dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 119. Argentina dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 120. Middle East and Africa dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 121. Middle East and Africa dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 122. Middle East and Africa dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 123. Middle East and Africa dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 124. Middle East and Africa dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 125. Middle East and Africa Dog Vaccine market, by region, 2018 - 2030 (USD Million)
  • 126. South Africa dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 127. South Africa dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 128. South Africa dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 129. South Africa dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 130. South Africa dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 131. Saudi Arabia dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 132. Saudi Arabia dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 133. Saudi Arabia dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 134. Saudi Arabia dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 135. Saudi Arabia dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 136. UAE dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 137. UAE dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 138. UAE dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 139. UAE dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 140. UAE dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 141. Kuwait dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 142. Kuwait dog vaccine market, by disease type, 2018 - 2030 (USD Million)]
  • 143. Kuwait dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 144. Kuwait dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 145. Kuwait dog vaccine market, by component, 2018 - 2030 (USD Million)

List of Figure

1. Market research process

2. Data triangulation techniques

3. Primary research pattern

4. Market research approaches

5. QFD modeling for market share assessment

6. Market formulation & validation

7. Dog Vaccines: Market outlook

8. Dog Vaccines: Competitive insights

9. Parent market outlook

10. Related/ancillary market outlook

11. Penetration and growth prospect mapping

12. Industry value chain analysis

13. Dog vaccine market driver impact

14. Dog vaccine market restraint impact

15. Dog vaccine market strategic initiatives analysis

16. Dog vaccine market: Vaccine type movement analysis

17. Dog vaccine market: Vaccine type outlook and key takeaways

18. Modified/ attenuated live market estimates and forecasts, 2018 - 2030

19. Inactivated (Killed) market estimates and forecasts, 2018 - 2030

20. Others market estimates and forecasts, 2018 - 2030

21. Dog vaccine market: Disease type movement analysis

22. Dog vaccine market: Disease type outlook and key takeaways

23. Canine distemper market estimates and forecasts, 2018 - 2030

24. Canine infectious respiratory disease complex (CIRDC)market estimates and forecasts, 2018 - 2030

25. Canine parvovirosis/ parvovirus disease market estimates and forecasts, 2018 - 2030

26. Canine Lyme disease market estimates and forecasts, 2018 - 2030

27. Infectious canine hepatitis market estimates and forecasts, 2018 - 2030

28. Canine rabies market estimates and forecasts, 2018 - 2030

29. Other diseases market estimates and forecasts, 2018 - 2030

30. Dog Vaccine market: Route of administration movement analysis

31. Dog Vaccine market: Route of administration outlook and key takeaways

32. Injectable market estimates and forecasts, 2018 - 2030

33. Intranasal market estimates and forecasts, 2018 - 2030

34. Oral market estimates and forecasts, 2018 - 2030

35. Dog Vaccine market: Duration of immunity movement analysis

36. Dog Vaccine market: Duration of immunity outlook and key takeaways

37. 1 year market estimates and forecasts, 2018 - 2030

38. 3-year market estimates and forecasts, 2018 - 2030

39. others market estimates and forecasts, 2018 - 2030

40. Dog Vaccine market: Component movement analysis

41. Dog Vaccine market: Component of immunity outlook and key takeaways

42. Combined vaccines market estimates and forecasts, 2018 - 2030

43. Mono vaccines market estimates and forecasts, 2018 - 2030

44. Global dog vaccine market: Regional movement analysis

45. Global dog vaccine market: Regional outlook and key takeaways

46. North America market estimates and forecasts, 2018 - 2030

47. U.S. market estimates and forecasts, 2018 - 2030

48. Canada market estimates and forecasts, 2018 - 2030

49. Europe market estimates and forecasts, 2018 - 2030

50. UK market estimates and forecasts, 2018 - 2030

51. Germany market estimates and forecasts, 2018 - 2030

52. France market estimates and forecasts, 2018 - 2030

53. Italy market estimates and forecasts, 2018 - 2030

54. Spain market estimates and forecasts, 2018 - 2030

55. Denmark market estimates and forecasts, 2018 - 2030

56. Sweden market estimates and forecasts, 2018 - 2030

57. Norway market estimates and forecasts, 2018 - 2030

58. Asia Pacific market estimates and forecasts, 2018 - 2030

59. Japan market estimates and forecasts, 2018 - 2030

60. China market estimates and forecasts, 2018 - 2030

61. India market estimates and forecasts, 2018 - 2030

62. Australia market estimates and forecasts, 2018 - 2030

63. Thailand market estimates and forecasts, 2018 - 2030

64. South Korea market estimates and forecasts, 2018 - 2030

65. Latin America market estimates and forecasts, 2018 - 2030

66. Brazil market estimates and forecasts, 2018 - 2030

67. Mexico market estimates and forecasts, 2018 - 2030

68. Argentina market estimates and forecasts, 2018 - 2030

69. Middle East and Africa. market estimates and forecasts, 2018 - 2030

70. Saudi Arabia market estimates and forecasts, 2018 - 2030

71. South Africa market estimates and forecasts, 2018 - 2030

72. UAE market estimates and forecasts, 2018 - 2030

73. Kuwait market estimates and forecasts, 2018 - 2030